The safety of biotechnological products used for medicinal products is addr
essed by EU council directives. The general principles and the regulatory f
ramework for the handling of new drug applications within this areas are de
scribed both with respect to benefit/risk evaluation, quality assessment, p
reclinical safety and efficacy testing.